Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.

The Alsace BioValley cluster has launched SHIP-In, a project to develop induced pluripotent stem cells for use in drug discovery.

A new institute of Complex Systems and Mathematical Biology was launched at Aberdeen University yesterday.

Personalised medicine will increase the number of alliances between diagnostic and pharmaceutical businesses, says a new report.